Quick Answer
STRATA Skin Sciences, Inc. reported Net Income Loss of -$6.26 million for the year ending 2025.
- STRATA Skin Sciences, Inc. showed an increase of +37.9% in Net Income Loss from 2024 to 2025.
- This data is from STRATA Skin Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: -$7.98 million | Q2 2014: $627.0 thousand | Q3 2014: -$2.29 million | Q1 2015: -$7.27 million | Q2 2015: -$7.85 million | Q3 2015: -$9.23 million | Q1 2016: -$1.44 million | Q2 2016: $498.0 thousand | Q3 2016: -$1.51 million | Q1 2017: -$3.97 million | Q2 2017: $2.46 million | Q3 2017: -$19.08 million | Q1 2018: -$2.08 million | Q2 2018: -$1.63 million | Q3 2018: -$608.0 thousand | Q1 2019: -$1.33 million | Q2 2019: -$1.08 million | Q3 2019: -$860.0 thousand | Q1 2020: -$1.04 million | Q2 2020: -$1.68 million | Q3 2020: -$1.25 million | Q1 2021: -$2.42 million | Q2 2021: $1.08 million | Q3 2021: -$521.0 thousand | Q1 2022: -$2.50 million | Q2 2022: -$1.89 million | Q3 2022: -$995.0 thousand | Q1 2023: -$2.84 million | Q2 2023: -$3.15 million | Q3 2023: -$1.05 million | Q1 2024: -$3.37 million | Q2 2024: -$91.0 thousand | Q3 2024: -$2.07 million | Q1 2025: -$2.12 million | Q2 2025: -$2.58 million | Q3 2025: -$1.62 million.
- Over the full 17 years of available data (2009 to 2025), STRATA Skin Sciences, Inc.'s Net Income Loss has grown by 66.1%.
- Historical annual values: Fiscal year 2025: -$6.26 million | Fiscal year 2024: -$10.09 million | Fiscal year 2023: -$10.83 million | Fiscal year 2022: -$5.55 million | Fiscal year 2021: -$2.71 million | Fiscal year 2020: -$4.41 million | Fiscal year 2019: -$3.79 million | Fiscal year 2018: -$4.03 million | Fiscal year 2017: -$21.51 million | Fiscal year 2016: -$3.34 million | Fiscal year 2015: -$24.95 million | Fiscal year 2014: -$14.15 million | Fiscal year 2013: -$25.95 million | Fiscal year 2012: -$22.67 million | Fiscal year 2011: -$20.38 million | Fiscal year 2010: -$19.92 million | Fiscal year 2009: -$18.45 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: